Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy, safety, and response predictors of Astragalus in patients with mild to moderate Alzheimer's disease: A study protocol of an assessor-blind, statistician-blind open-label randomized controlled trial

Published:2024-10 Issue: Volume:41 Page:101339
ISSN:2451-8654
Container-title:Contemporary Clinical Trials Communications
language:en
Short-container-title:Contemporary Clinical Trials Communications

Author:

Cheng Yingzhe^ORCID,Lin Lin^ORCID,Huang Peilin^ORCID,Zhang Jiejun^ORCID,Pan Xiaodong^ORCID

Funder

Fujian Provincial Department of Finance

Science and Technology Projects of Fujian Province

Publisher

Elsevier BV

Reference61 articles.

1. World Alzheimer Report,2021

2. Alzheimer's disease facts and figures;Alzheimer's Dementia : the journal of the Alzheimer's Association,2023

3. Cognitive symptoms of Alzheimer's disease: clinical management and prevention;Joe;Br. Med. J.,2019

5. Anti-neuroinflammatory potential of natural Products in attenuation of Alzheimer's disease;Shal;Front. Pharmacol.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP